INNOVATE Corp. VATE
7.77
0.25
3.32%
as of 25 Sep
- Market cap
- $102.6M
- P/E
- 0.0×
Follow VATE
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.06 | 0.05 | 0.06 | 0.16 | |
P/FCF ratio |
1.03 | 0.49 | 0.43 | 2.35 | |
P/Operating CF |
3.38 | 0.59 | 1.67 | (10.15) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.64 | 0.44 | 0.46 | 0.51 | |
EV/EBITDA |
10.33 | 6.65 | 6.94 | 6.41 | |
EV/Operating CF |
8.04 | 3.75 | 3.01 | 5.51 | |
EV/FCF |
11.14 | 4.52 | 3.54 | 7.32 | |
Quick Ratio |
0.31 | 0.34 | 0.31 | 0.34 | |
Current Ratio |
0.43 | 0.44 | 0.40 | 0.44 | |
Net Debt/EBITDA |
32.66 | 17.59 | 23.19 | 10.44 | |
Debt/Assets |
73.27% | 63.04% | 72.54% | 61.19% | |
Debt/Equity |
(3.24) | (2.76) | (2.91) | (2.81) | |
Asset Turnover |
1.22 | 1.35 | 1.48 | 1.60 | |
Operating CF/Net income |
(2.04) | (12.96) | (2.65) | (2.37) | |
Capex/Depreciation |
(0.57) | (0.55) | (0.71) | (0.63) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.41% | 10.61% | 10.80% | 9.84% | |
Intangible Assets out of Total Assets |
0.32 | 0.16 | 0.31 | 0.15 | |
Share Based Compensation of Revenue |
0.20% | 0.13% | 0.16% | 0.09% | |
Graham Net Nets |
(10.78) | (11.98) | (10.08) | (2.99) | |
Graham Number |
45.12 | 43.21 | 41.73 | 26.60 | |
Earnings Yield |
(113.70%) | (107.30%) | (74.82%) | (9.86%) | |
Free Cash Flow Yield |
96.66% | 204.03% | 231.53% | 42.57% | |
Revenue per Share |
26.17 | 28.95 | 27.34 | 31.52 | |
Operating CF per Share |
1.45 | 7.65 | 3.41 | (1.84) | |
Capex per Share |
(0.57) | (0.57) | (0.72) | (0.76) | |
Free Cash Flow per Share |
0.87 | 7.08 | 2.69 | (2.60) | |
Cash per Share |
2.68 | 8.19 | 10.09 | 6.56 | |
Shareholders Equity per Share |
(15.59) | (16.41) | (17.50) | (16.37) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(15.59) | (16.41) | (17.50) | (16.37) | |
Free Cash Flow |
11.60 | 93.60 | 35.90 | (34.80) | |
Working Capital |
(553.70) | (582.70) | (613.90) | (604.10) | |
Capital Expenditures |
(7.60) | (7.50) | (9.60) | (10.20) | |
Net Current Asset Value |
(699.40) | (715.60) | (764.40) | (746.30) | |
EV/EBIT |
41.33 | 19.18 | 17.59 | 11.99 | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.02 | |
Net Profit Margin |
(2.71%) | (2.04%) | (4.71%) | 2.47% | |
Price to Operating Income |
3.84 | 2.08 | 2.15 | 3.85 | |
| Other line items | |||||
Average Receivables |
228.20 | 216.70 | 175.25 | 263.55 | |
Average Payables |
91.80 | 112.65 | 117.45 | 108.70 | |
Average Inventory |
19.55 | 18.40 | 17.55 | 17.75 | |
Average Assets |
905.20 | 920.60 | 902.40 | 948.80 | |
Average Common Equity |
(178.50) | (192.75) | (213.65) | (217.50) |
Columns are period end dates